PIERRE BLANCHARD

Has grant

Adjunct Associate Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

PIERRE BLANCHARD is an Adjunct Associate Professor at The University of Texas MD Anderson Cancer Center in the United States. His research areas encompass various aspects of radiation oncology, including treatment strategies for head and neck cancers, the application of digital pathology in prostate cancer, and innovations in radiotherapy. He has contributed to several recent articles focusing on oncologic outcomes and treatment methodologies for malignancies, specifically addressing human papillomavirus-related oropharyngeal cancers and locally advanced sinonasal cancers.

Recent Grants

Grant: Close

Update of the Meta-analysis of Chemotherapy in Head and Neck Cancer to include 17 new trials representing 2874 patients

Open Date: 2012-01-02

Close Date: 2015-01-02

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Eric Wegener

Newcastle University

AUSTRALIA

View details

Christine Do Cao

FRANCE

View details

Marianne Aznar

University of Manchester

UNITED KINGDOM

View details

Josep M Borras

Professor

University of Barcelona

SPAIN

View details

Robert Dess

University of Michigan

UNITED STATES

View details

Yolande Lievens

Associate Professor Radiation Oncology

UGent

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

PIERRE BLANCHARD

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Intensification or de-escalation? What is the standard treatment for human papillomavirus-related oropharyngeal cancers in 2025?

oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer − a systematic review and expert consensus

Safety and Oncologic Outcomes of Endoscopic Endonasal Transcribriform Approach for Locally Advanced Sinonasal Malignancies

A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancers

Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey

Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Driving innovation in radiation oncology in a changing world: the Green Journal’s roadmap for the next decade

A systematic literature review of definitions and classification systems for radiotherapy innovation: a first step towards building a value-based assessment tool for radiation oncology

Adjuvant or Salvage Radiation Therapy for Prostate Cancer after Prostatectomy: Current Status, Controversies and Perspectives

Anaplastic Thyroid Carcinoma: An Update

Second malignancy (SM) in prostate cancer patients treated with SBRT and other contemporary radiation techniques

Prognostic value and therapeutic implications of nodal involvement in head and neck mucosal melanoma

Collaborators (6)

Eric Wegener

Christine Do Cao

Marianne Aznar

Josep M Borras

Robert Dess

Yolande Lievens

Make your next move.